Innsbrook 5/23/2021 TABLE OF CONTENTS SDS0618 Adacel 1 Sanofi Pasteur 1/22/2019 SDS0507 Albuterol Sulfate Inhalation Solution 2 Nephron Pharmaceuticals Corporation 2/1/2017 SDS1134 Ammonia Inhalants 3 Dynarex Corporation 1/14/2015 SDS1253 Betamethasone Sodium Phosphate and Betamethasone Acetate 4 Injectable Suspension, USP PharmaForce, Inc 8/14/2015 SDS1255 BYDUREON MIXTURE FOR INJECTION 5 ASTRAZENECA PTY LTD 8/8/2016 SDS1257 Bystolic Exemption Letter 6 Allergan 3/1/2018 SDS0430 Ceftriaxone for Injection 7 Hospira, A Pfizer Company 10/28/2016 SDS0338 CETYLCIDE II 8 Cetylite Industries, Inc 11/3/2016 SDS0513 Cyanocobalamin Injection, USP 9 West-Ward Pharmaceuticals 3/15/2016 SDS0417 ENGERIX-B ADULT 10 GlaxoSmithKline US 5/29/2018 SDS0431 Ethyl Chloride 11 Gebauer Company 4/23/2013 SDS1254 Fluorescein GloStrips, Ophthalmic 12 Nomax, Inc. 5/14/2015 SDS0414 Gardasil® 13 Merck & Co., Inc 11/15/2016 SDS0602 Grafco Silver Nitrate Applicators 14 GF Health Products, Inc. 9/19/2014 SDS0494 KENALOG®-10 and 40 mg/ml (triamcinolone acetonide) 15 Injectable Suspension Pfizer Pharmaceuticals Group 2/24/2015 SDS0429 Ketorolac Tromethamine Injection, USP 16 Hospira, A Pfizer Company 8/3/2016 SDS1249 LANTUS 17 Sanofi -aventis 11/16/2016 SDS0386 McKesson Hydrogen Peroxide, 3% 18 McKesson Medical-Surgical Inc. 10/29/2015 SDS1128 McKesson Iodoform Packing Strip, 5% 19 McKesson Medical-Surgical Inc. 9/1/2015 SDS0492 McKesson Isopropyl Rubbing Alcohol 70% 20 McKesson Medical-Surgical Inc. 8/7/2015 SDS1124 McKesson Multi-Enzymatic Cleanser Fresh Mint Fragrance 21 McKesson Medical-Surgical Inc. 9/18/2015 SDS0549 Menactra 22 Sanofi Pasteur 4/16/2015 SDS0508 Nitroglycerin Tablets (0.4, and 0.6 mg) 23 Pfizer Pharmaceuticals Group 3/28/2016 SDS1031 Nitrostat tablets (0.3 mg) 24 Pfizer Pharmaceuticals Group 3/28/2016 SDS1244 Novalin N 25 Novo Nordisk A/S 1/23/2015 SDS1243 Novolin 70/30 26 Novo Nordisk A/S 1/23/2015 SDS1245 Novolin R 27 Novo Nordisk A/S 1/23/2015 SDS1252 ONDANSETRON Exemption Letter 28 Sandoz GmbH 11/30/2018 SDS1241 Ozempic® (Semaglutide) for Injection 29 Novo Nordisk A/S 1/22/2018 SDS0437 PNEUMOVAX™ 23 30 Merck & Co., Inc 4/1/2010 SDS1251 Repatha® 31 Amgen Inc 1/20/2017 SDS0413 SELECT Povidone Iodine, USP Swabsticks 32 McKesson Medical-Surgical Inc. 11/11/2015 SDS0550 Select® PVP Prep Solution 33 McKesson Medical-Surgical Inc. 11/20/2015 SDS0516 Silvadene Cream (Silver sulfadiazine) 34 Pfizer Pharmaceuticals Group 11/7/2017 SDS0404 Sodium Chloride Irrigation 35 Hospira, A Pfizer Company 10/25/2016 SDS1250 SOLIQUA 100/33TM 36 Sanofi -aventis 10/24/2016 SDS1242 Tresiba® 100 U/ml, 200 U/ml 37 Novo Nordisk A/S 9/10/2015 SDS1256 Triamcinolone Acetonide Injection (10 or 40 mg/ml) 38 Amneal Pharmaceuticals Pvt. Ltd. 2/15/2016 SDS1247 Trulicity™ 39 Eli Lilly and Company 5/23/2017 SDS1246 XOLAIR(R) Vials (150 mg) 40 Genentech, Inc. 4/1/2014 SDS1240 Xultophy ®, Insulin Degludec + Liraglutide 41 Novo Nordisk A/S 12/11/2014 1111 US - OSHA SAFETY DATA SHEET Issue Date 17-Apr-2015 Revision Date 22-Jan-2019 Version 5 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND OF THE COMPANY/UNDERTAKING Product identifier Adacel® Product Name Other means of identification Product Information Syringe, without needle, 1 dose in package of 5 syringes Vial, 1 dose in package of 10 vials Synonyms Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed Recommended use of the chemical and restrictions on use Recommended Use Active booster immunization against tetanus, diphtheria and pertussis. Uses advised against Not available. Details of the supplier of the safety data sheet Supplier Address Sanofi Pasteur Discovery Drive Swiftwater, PA 18370 Phone: 1-800-822-2463 (1-800-VACCINE) Emergency telephone number 24 Hour Emergency Phone 1-703-741-5970 / 1-800-424-9300 CNN # 2118 (CHEMTREC) 2. HAZARDS IDENTIFICATION Classification Health Hazards Not classified. Physical Hazards Not classified. OSHA Regulatory Status This product is a vaccine that is safe for consumers when used according to the label directions. Potential hazards that may occur if product is not used according to the consumer label are as follows throughout the sheet. Label elements Emergency Overview Normal precautions common to safe manufacturing practice should be followed in handling and storage. Appearance Uniform, white, cloudy Physical State Liquid Odor Not available. suspension Hazards not otherwise classified (HNOC) Not available. _____________________________________________________________________________________________ Page 1 / 7 1111 ADACEL Tetanus Toxoid, Reduced Diphtheria Toxoid Revision Date 22-Jan-2019 and Acellular Pertussis Vaccine Adsorbed _____________________________________________________________________________________________ 3. COMPOSITION/INFORMATION ON INGREDIENTS Synonyms Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed. Chemical Name CAS No. Weight-% Tetanus Toxoid Adsorbed N/A N/A Diphtheria Toxoid Adsorbed N/A N/A Pertussis (acellular, component) N/A 0.0005 Fimbriae Types 2 and 3 Adsorbed (FIM) N/A 0.001 Filamentous Haemagglutinin Adsorbed (FHA) N/A 0.001 Pertactin Adsorbed N/A 0.0006 Water 7732-18-5 q.s to 100 Note: Ingredients below reportable levels are not listed. 4. FIRST AID MEASURES First aid measures Eye Contact In case of eye contact, immediately flush eyes with fresh water for at least 15 minutes while holding the eyelids open. Remove contact lenses if worn. Get medical attention if irritation persists. Skin Contact In case of contact, remove contaminated clothing. Immediately flush skin with copious amounts of water for at least 15 minutes. Obtain medical attention if skin reaction occurs. Inhalation In case of inhalation, remove to fresh air. If breathing is difficult, administer oxygen. Seek medical attention immediately. Ingestion In case of accidental ingestion, wash out mouth with copious amounts of water. Seek medical attention immediately. Do not induce vomiting unless directed by medical personnel. Never give anything by mouth to an unconscious person. Self-Protection of the First Aider Do not use mouth-to-mouth method if victim ingested or inhaled the substance; give artificial respiration with the aid of a pocket mask equipped with a one-way valve or other proper respiratory medical device. Most important symptoms and effects, both acute and delayed Symptoms Common effects of the vaccine include the following: pain, swelling, and erythema of the injection site; headache; body ache or muscle weakness; tiredness. Indication of any immediate medical attention and special treatment needed Note to physicians Treat symptomatically. 5. FIRE-FIGHTING MEASURES Suitable extinguishing media Use extinguishing measures that are appropriate to local circumstances and the surrounding environment. Unsuitable Extinguishing Media None known. Specific hazards arising from the chemical Not available. Hazardous Combustion Products Not available. Explosion data _____________________________________________________________________________________________ Page 2 / 7 1111 ADACEL Tetanus Toxoid, Reduced Diphtheria Toxoid Revision Date 22-Jan-2019 and Acellular Pertussis Vaccine Adsorbed _____________________________________________________________________________________________ Sensitivity to Mechanical Impact Not available. Sensitivity to Static Discharge None known. Protective equipment and precautions for firefighters As in any fire, wear self-contained breathing apparatus pressure-demand, MSHA/NIOSH (approved or equivalent) and full protective gear. 6. ACCIDENTAL RELEASE MEASURES Personal precautions, protective equipment and emergency procedures Personal Precautions Wear appropriate personal protective equipment (see Section 8). Environmental precautions Environmental Precautions See Section 12 for additional ecological information. Methods and material for containment and cleaning up Methods for Containment Prevent further leakage or spillage if safe to do so. Methods for Cleaning up Wipe up with absorbent material (e.g. cloth) for disposal. Area where spill occurred can be cleaned with the regular cleaning materials designated for the area. 7. HANDLING AND STORAGE Precautions for safe handling Advice on Safe Handling Handle in accordance with good industrial hygiene and safety practice. Conditions for safe storage, including any incompatibilities Storage Conditions Store at 2° to 8°C (35° to 46°F). Do not freeze. Incompatible Materials Not available. 8. EXPOSURE CONTROLS/PERSONAL PROTECTION Control parameters Exposure Guidelines This product, as supplied, does not contain any hazardous materials with Occupational Exposure Limits (OEL) established by the region specific regulatory bodies. Appropriate engineering controls Engineering Controls Used as supplied, no special engineering controls are needed when administering the vaccine. Individual protection measures, such as personal protective equipment Eye/face Protection In laboratory or industrial settings, safety glasses with side shields are recommended. Skin and Body Protection In laboratory or industrial settings, gloves and lab coats are recommended. Respiratory Protection Used as supplied, general room ventilation is acceptable and no special respiratory protection is needed when administering the vaccine. General Hygiene Considerations Always observe good personal hygiene measures, such as washing after handling the material and before eating, drinking, and/or smoking. Routinely wash work clothing and protective equipment. 9. PHYSICAL AND CHEMICAL